Richmond Brothers Inc. Sells 45,423 Shares of Rockwell Medical, Inc. (NASDAQ:RMTI)

Richmond Brothers Inc. cut its holdings in shares of Rockwell Medical, Inc. (NASDAQ:RMTI) by 14.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 276,828 shares of the company’s stock after selling 45,423 shares during the period. Rockwell Medical comprises approximately 1.0% of Richmond Brothers Inc.’s investment portfolio, making the stock its 14th biggest position. Richmond Brothers Inc. owned 0.91% of Rockwell Medical worth $487,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. SkyOak Wealth LLC lifted its stake in shares of Rockwell Medical by 47.3% in the 1st quarter. SkyOak Wealth LLC now owns 25,110 shares of the company’s stock valued at $42,000 after acquiring an additional 8,065 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after acquiring an additional 92,189 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Rockwell Medical by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after acquiring an additional 43,302 shares during the last quarter. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Stock Up 2.0 %

Shares of NASDAQ:RMTI opened at $4.02 on Thursday. The firm has a market cap of $121.87 million, a P/E ratio of -11.17 and a beta of 1.47. The company has a quick ratio of 1.60, a current ratio of 2.00 and a debt-to-equity ratio of 0.41. Rockwell Medical, Inc. has a 12-month low of $1.16 and a 12-month high of $4.38. The business has a fifty day simple moving average of $2.62 and a 200 day simple moving average of $2.00.

Rockwell Medical (NASDAQ:RMTI) last announced its earnings results on Thursday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.05. The business had revenue of $25.83 million during the quarter, compared to analyst estimates of $23.01 million. Rockwell Medical had a negative return on equity of 6.96% and a negative net margin of 5.06%. During the same period last year, the company earned ($0.18) EPS. Analysts predict that Rockwell Medical, Inc. will post -0.03 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on RMTI. StockNews.com upgraded Rockwell Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, June 19th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 target price on shares of Rockwell Medical in a research report on Wednesday, September 11th.

Rockwell Medical Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.